CN100548998C - 马来酸桂哌齐特晶型及其制备方法 - Google Patents
马来酸桂哌齐特晶型及其制备方法 Download PDFInfo
- Publication number
- CN100548998C CN100548998C CNB2008100939669A CN200810093966A CN100548998C CN 100548998 C CN100548998 C CN 100548998C CN B2008100939669 A CNB2008100939669 A CN B2008100939669A CN 200810093966 A CN200810093966 A CN 200810093966A CN 100548998 C CN100548998 C CN 100548998C
- Authority
- CN
- China
- Prior art keywords
- cinepazide maleate
- anhydrous
- cinepazide
- crystal form
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2008100939669A CN100548998C (zh) | 2008-02-01 | 2008-04-24 | 马来酸桂哌齐特晶型及其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100067862A CN101225075A (zh) | 2008-02-01 | 2008-02-01 | 马来酸桂哌齐特晶型及其制备方法 |
CN200810006786.2 | 2008-02-01 | ||
CNB2008100939669A CN100548998C (zh) | 2008-02-01 | 2008-04-24 | 马来酸桂哌齐特晶型及其制备方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910162811A Division CN101659646A (zh) | 2008-02-01 | 2008-04-24 | 马来酸桂哌齐特晶型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101376648A CN101376648A (zh) | 2009-03-04 |
CN100548998C true CN100548998C (zh) | 2009-10-14 |
Family
ID=39857311
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100067862A Pending CN101225075A (zh) | 2008-02-01 | 2008-02-01 | 马来酸桂哌齐特晶型及其制备方法 |
CN200910162811A Pending CN101659646A (zh) | 2008-02-01 | 2008-04-24 | 马来酸桂哌齐特晶型及其制备方法 |
CNB2008100939669A Active CN100548998C (zh) | 2008-02-01 | 2008-04-24 | 马来酸桂哌齐特晶型及其制备方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100067862A Pending CN101225075A (zh) | 2008-02-01 | 2008-02-01 | 马来酸桂哌齐特晶型及其制备方法 |
CN200910162811A Pending CN101659646A (zh) | 2008-02-01 | 2008-04-24 | 马来酸桂哌齐特晶型及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN101225075A (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101735172B (zh) * | 2008-11-04 | 2012-07-11 | 北京四环制药有限公司 | 桂哌齐特一水合物、晶型及其制备方法 |
CN101708179B (zh) * | 2009-08-17 | 2011-06-01 | 北京四环制药有限公司 | 一种安全性高的桂哌齐特药用组合物及其制备方法和其应用 |
CN102100695B (zh) * | 2009-08-17 | 2012-01-11 | 北京四环制药有限公司 | 一种安全性高的桂哌齐特药用组合物及其制备方法和其应用 |
-
2008
- 2008-02-01 CN CNA2008100067862A patent/CN101225075A/zh active Pending
- 2008-04-24 CN CN200910162811A patent/CN101659646A/zh active Pending
- 2008-04-24 CN CNB2008100939669A patent/CN100548998C/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101225075A (zh) | 2008-07-23 |
CN101376648A (zh) | 2009-03-04 |
CN101659646A (zh) | 2010-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE028884T2 (en) | A new polymorphic form of imatinib mesylate and a process for its production | |
CN103360446A (zh) | 大环内酯固态晶型 | |
CN102875531B (zh) | 一种(r)-兰索拉唑无水晶型及其制备方法 | |
CN100548998C (zh) | 马来酸桂哌齐特晶型及其制备方法 | |
CN105061420B (zh) | 一种jak抑制剂的晶型及其制备方法和应用 | |
CN108947949B (zh) | 抗焦虑氘代化合物及其医药用途 | |
CN107793368A (zh) | 达可替尼溶剂化物、其新晶型及其制备方法和用途 | |
CN106317020A (zh) | 富马酸沃诺拉赞晶型α及其制备方法 | |
US20170051002A1 (en) | Rebaudioside A Crystal And Its Preparation Method And Use | |
WO2018214877A1 (zh) | 一种地佐辛晶型及其制备方法 | |
CN106478636B (zh) | 替格瑞洛晶型及制备方法 | |
CN103059013B (zh) | 达沙替尼一水合物的晶型及其制备方法 | |
CN112110865B (zh) | 一种异烟酰胺阿西莫司共晶体ⅱ及其制备方法 | |
CN101347412A (zh) | 三水合氨磷汀结晶冻干制剂及其制备方法 | |
CN114057656A (zh) | 一种法匹拉韦共晶及其制备方法 | |
Zhang et al. | A drug–drug cocrystal and a co-amorphous form, prepared from honokiol and ligustrazine, inspired by Chinese patent medicine | |
US9834540B2 (en) | Omeprazole Sodium semihydrate and preparation method thereof | |
CN103012267B (zh) | 盐酸贝那普利结晶型物及其制备方法 | |
CN114276350B (zh) | 一种酮咯酸与吩嗪共晶及其制备方法 | |
CN104610208B (zh) | (1s)‑1,6‑二脱氧‑1‑[4‑甲氧基‑3‑(反式‑4‑正丙基环己基)甲基苯基]‑d‑吡喃葡萄糖的晶型a及其制备方法和应用 | |
CN103254088B (zh) | 盐酸他喷他多晶型d及其制备方法和应用 | |
JPH02292287A (ja) | プテリジン化合物及び該化合物を含有する抗不整脈、心臓保護、抗カリ尿及び利尿作用を有する組成物 | |
CN115850105B (zh) | 一种甲基多巴与脯氨酸的共结晶及其制备方法与应用 | |
CN112707829B (zh) | 一种妥洛特罗晶型及制备方法 | |
CN105503838A (zh) | 曲沙他滨的合成及其晶型 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TONGHUA SIHUAN PHARMACEUTICAL CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20111115 Address after: 101114 Beijing city Tongzhou District three Airport Hospital Beijing Sihuan Pharmaceutical Co. Ltd. Co-patentee after: Tonghua Sihuan Pharm Co., Ltd. Patentee after: Beijing Sihuan Pharmaceutical Co., Ltd. Address before: 101114 Beijing city Tongzhou District three Airport Hospital Beijing Sihuan Pharmaceutical Co. Ltd. Patentee before: Beijing Sihuan Pharmaceutical Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 101114 Beijing city Tongzhou District three Airport Hospital Beijing Sihuan Pharmaceutical Co. Ltd. Patentee after: Beijing Sihuan Pharmaceutical Co., Ltd. Patentee after: Tonghua Jida Pharmaceutical Co., Ltd. Address before: 101114 Beijing city Tongzhou District three Airport Hospital Beijing Sihuan Pharmaceutical Co. Ltd. Patentee before: Beijing Sihuan Pharmaceutical Co., Ltd. Patentee before: Tonghua Sihuan Pharm Co., Ltd. |